Charterhouse Capital Partners Invests in PHASTAR
January 5, 2021
Charterhouse Capital Partners has made a growth investment in PHASTAR, a specialist biometrics clinical research organisation (CRO). PHASTAR founder Kevin Kane remains CEO and a significant shareholder; Charterhouse will support the company's geographic expansion and capability growth while Nick Edwards joins as non-executive chair.
- Targets
- PHASTAR
- Industry
- Healthcare Services
- Location
- England, United Kingdom
- Transaction Type
- Growth capital
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.